The launch of the Elemis Red Light Mask is one the brightest ideas we’ve had when it comes to embodying our high-touch, high-tech philosophy – Noella Gabriel, Elemis CEO and co-founder

Elemis has branched into LED skincare with the launch of its breakthrough Red Light Mask. Now available as a professional treatment add-on and at-home solution, the age-defying light therapy device offers triple-action wavelength power, clinically proven results and an optimised design and fit.

Demand for LED skincare is rising fast – and with its philosophy of high-tech, high-touch treatments, Elemis is leveraging its reputation for results-driven products. With searches for ‘LED mask’ up 57 per cent globally in the past year (Google Trends) and 60 per cent of consumers looking for solutions to support natural ageing (McKinsey, 2025), Elemis' new Red Light Mask offers a timely and exciting opportunity for both spas and retailers.

With just 10 minutes of consistent use, the mask is clinically proven to reveal a brighter, smoother and rejuvenated complexion.* And the technology is impressive: precision-engineered diodes create 100 per cent uniform light coverage, while wavelengths of 630 nanometres (nm), 830nm and 1070nm can penetrate skin at different depths. Made with medical-grade silicone for an optimised fit, this professional-level treatment will visibly improve the appearance of brightness, smoothness and redness.

Noella Gabriel, Elemis CEO and co-founder said: "The launch of the Elemis Red Light Mask is one of the brightest ideas we’ve had when it comes to embodying our high-touch, high-tech philosophy. This is cutting-edge precision-engineered technology. Pair it with our sensorial, results-driven formulas and you’re surely onto a winner. 

"It comfortably moulds to your facial contours, making it effortless to wear. It’s firmly part of my daily routine and I encourage you to make it part of yours, whether you invest in your own to use at home or choose it as an add-on at your next facial."

The Elemis Red Light Mask's RRP is £350, €440 or US$475.

For further details, please reach out to [email protected]

*iSmart Clinical Study Document (0001-Rep-001), 2019. Results based on 25 people over 4 weeks and iSmart Study_0001-Rep-002, 2020. Results based on 19 people over 4 weeks.